Form 4 for WST West Pharmaceutical Services
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-30 · accession 0001562180-23-004627 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-31 | 2023-05-30 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +1,000 | 2,830 | +55% | +$102.5K |
| D | 2023-05-31 | 2023-05-30 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $343.05 | -1,000 | 1,830 | -35% | -$343.1K |
| D | 2023-05-31 | 2023-05-30 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -1,000 | 1,548 | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-30 | M | A | 1,000 | $102.51 | 2,829.50 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-30 | S | D | 1,000 | $343.05 | 1,829.50 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2023-05-30 | M | D | 1,000 | $0.00 | 1,548 | D | $102.51 · 2020-02-19 to 2029-02-19 | 1,000 Common Stock |